<DOC>
	<DOCNO>NCT00000749</DOCNO>
	<brief_summary>To evaluate healthy volunteer safety immune response 200 mcg gp120 candidate vaccine MF59 emulsion without MTP-PE 0 , 1 6 month . Preliminary evaluation two dose level gp120 administer volunteer protocol VEU 007A indicate gp120 dose potentially great immunogenicity may interest .</brief_summary>
	<brief_title>A Phase I Clinical Trial Evaluate Safety Immunogenicity 200 Mcg gp120 ( CHO ) BIOCINE MF59 Emulsion Versus Emulsion Control : Three Injections 0 , 1 , 6 Months</brief_title>
	<detailed_description>Preliminary evaluation two dose level gp120 administer volunteer protocol VEU 007A indicate gp120 dose potentially great immunogenicity may interest . Ten healthy volunteer receive 200 mcg gp120 MF59 emulsion , four volunteer receive placebo consist MF59 emulsion PBS vehicle . Injections give month 0 , 1 , 6 . Patients follow 12 month follow third injection .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Subjects must : Normal history physical exam . Negative ELISA HIV . Normal cellmediated immune response use Merieux skin test . Normal urinalysis . Exclusion Criteria Coexisting Condition : Subjects follow condition exclude : Evidence psychological psychiatric problem may lead noncompliance study requirement . Positive syphilis serology . If serology document false positive due remote ( &gt; 6 month ) treat infection , subject eligible . Circulating hepatitis B surface antigen . Subjects follow prior condition exclude : History immunodeficiency , chronic illness , autoimmune disease , use immunosuppressive medication . History anaphylaxis adverse reaction vaccine . Prior Medication : Excluded : Prior HIV vaccine . Immunoglobulins vaccine within past 3 month . Experimental agent within past 30 day . Prior Treatment : Excluded : Blood transfusion cryoprecipitates within past 3 month . Identifiable highrisk behavior HIV infection , include : Any history intravenous ( IV ) drug use within past year . Syphilis , gonorrhea , sexually transmit disease ( include chlamydia pelvic inflammatory disease ) past 6 month . More two sexual partner , sexual contact highrisk partner , past 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>HIV Envelope Protein gp120</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>